Use of Ranolazine in the Prevention and Treatment of Postoperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery

Abstract

Get full access to this article

View all access options for this article.

References

Tsu

Lee

. Use of ranolazine in the prevention and treatment of postoperative atrial fibrillation in patients undergoing cardiac surgery. Ann Pharmacother. 2014;48:633-637.

Miles

Passman

Murdock

. Comparison of effectiveness and safety of ranolazine versus amiodarone for preventing atrial fibrillation after coronary artery bypass grafting. Am J Cardiol. 2011;108:673-676.

Vizzardi

D’Aloia

Quinzani

. A focus on antiarrhythmic properties of ranolazine. J Cardiovasc Pharmacol Ther. 2012;17:353-356.

William Beaumont Hospitals. Suppression of atrial fibrillation with ranolazine after cardiac surgery. http://clinicaltrials.gov/ct2/show/NCT01352416. Accessed March 31, 2014.

North Shore Long Island Jewish Health System. Randomized double blind control trial on effects of ranolazine on new onset atrial fibrillation. http://clinicaltrials.gov/ct2/show/NCT01590979. Accessed March 31, 2014.